7-甲基-1H-吲哚-5-羧酸 | 180624-00-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 7-甲基-1H-吲哚-5-羧酸
• 英文名称: 7-methyl-1H-indole-5-carboxylic acid
• CAS: 180624-00-4
• 化学式: C₁₀H₉NO₂
• 分子量: 175.187
• InChiKey: OAWWSPFYTYUIHU-UHFFFAOYSA-N

物化性质

• 沸点：
  409.5±25.0 °C(Predicted)
• 密度：
  1.340±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  53.1
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
• 危险性描述：
  H302,H315,H319,H335

反应信息

• 作为反应物：
  描述：

  7-甲基-1H-吲哚-5-羧酸 在 copper(I) oxide 作用下， 以 喹啉 为溶剂， 反应 4.0h， 以50%的产率得到7-甲基吲哚
  参考文献：
  名称：

  Efficient Reagents for the Synthesis of 5-, 7-, and 5,7-Substituted Indoles Starting from Aromatic Amines:  Scope and Limitations

  摘要：

  Upon reaction with IPy(2)BF(4), 4-substituted anilines give regioselectively the corresponding o-iodoanilines in nearly quantitative yield, in a process that can be carried out on a multigram scale. Palladium-catalyzed coupling of the resulting 2-iodoanilines with (trimethylsilyl)acetylene (TMSA), followed by efficient CuI-mediated nitrogen cyclization onto alkynes with concurrent elimination of the TMS substituent, allows a straightforward elaboration of 5-mono- and 5,7-disubstituted indoles from aromatic amines. This new approach to the aforementioned indoles does not requires protective groups on nitrogen at any step and can be adapted for preparing related 7-manosubstituted indoles. Moreover, examples iterating the process are given, allowing bis-annulation and sequential double annulation and resulting in synthesis of benzodipyrroles. Additionally, suitable conditions for iodination of some of the target indoles with IPy(2)BF(4) are discussed.

  DOI：

  10.1021/jo952119+
• 作为产物：
  描述：

  4-氨基-3-甲基苯甲酸甲酯 在 bis-triphenylphosphine-palladium(II) chloride 、 copper(l) iodide 氢氧化钾 、 copper(l) iodide 、 三氟甲磺酸 、 水 、 bis(pyridine)iodonium tetrafluoroborate 、 三乙胺 作用下， 以 乙醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 45.5h， 生成 7-甲基-1H-吲哚-5-羧酸
  参考文献：
  名称：

  Efficient Reagents for the Synthesis of 5-, 7-, and 5,7-Substituted Indoles Starting from Aromatic Amines:  Scope and Limitations

  摘要：

  Upon reaction with IPy(2)BF(4), 4-substituted anilines give regioselectively the corresponding o-iodoanilines in nearly quantitative yield, in a process that can be carried out on a multigram scale. Palladium-catalyzed coupling of the resulting 2-iodoanilines with (trimethylsilyl)acetylene (TMSA), followed by efficient CuI-mediated nitrogen cyclization onto alkynes with concurrent elimination of the TMS substituent, allows a straightforward elaboration of 5-mono- and 5,7-disubstituted indoles from aromatic amines. This new approach to the aforementioned indoles does not requires protective groups on nitrogen at any step and can be adapted for preparing related 7-manosubstituted indoles. Moreover, examples iterating the process are given, allowing bis-annulation and sequential double annulation and resulting in synthesis of benzodipyrroles. Additionally, suitable conditions for iodination of some of the target indoles with IPy(2)BF(4) are discussed.

  DOI：

  10.1021/jo952119+

文献信息

• [EN] SUBSTITUTED OXAZOLINES AS ANTIPROLIFERATIVE AGENTS<br/>[FR] ANTIPROLIFERANTS A BASE D'OXAZOLINES SUBSTITUEES
  申请人：ABBOTT LAB

  公开号：WO2000006556A1

  公开（公告）日：2000-02-10

  Compounds having Formula (I) are useful for treating cancer. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), and methods of treating cancer in a mammal.

  具有化学式（I）的化合物对于治疗癌症是有用的。本发明还揭示了包含化学式（I）化合物的制药组合物以及治疗哺乳动物癌症的方法。
• Oxazoline antiproliferative agents
  申请人：Abbott Laboratories

  公开号：US06228868B1

  公开（公告）日：2001-05-08

  Compounds having Formula I are useful for treating cancer. Also disclosed are pharmaceutical compositions comprising compounds of Formula I, and methods of treating cancer in a mammal.

  具有I式的化合物对于治疗癌症是有用的。本文还公开了包括I式化合物的制药组合物以及在哺乳动物中治疗癌症的方法。
• US6228868B1
  申请人：——

  公开号：US6228868B1

  公开（公告）日：2001-05-08
• [EN] NOVEL ACC INHIBITORS<br/>[FR] NOUVEAUX INHIBITEURS DE L'ACC
  申请人：[en]PFIZER INC.

  公开号：WO2024023727A1

  公开（公告）日：2024-02-01

  A compound having the structures: Formulae (Ia) or (Ib) or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, wherein; R selected from the group consisting of H, C1-C6alkyl, C1-C6alkoxy and -(CH2)m-W, where W is C3-C8cycloalkyl, bicycloalkyl, bridged bicycloalkyl, phenyl,, 5- or 6-membered heteroaryl or heterocyclic containing one, two or three heteroatoms selected from the group consisting of N, S and O atoms; wherein each of said alkyl, cycloalkyl, alkoxy, heterocyclic, phenyl, naphthyl or heteroaryl may be unsubstituted or substituted by phenyl, halo, cyano, deuterium, hydroxy, C1-C6alkyl, C1-C6alkoxy, -SO2-R', - CONR'R", NR'COR", -NR'CONR'R", -NR'CO2R", -(CH2)n-SO2-R', -NHSO2-R', -NR"SO2-R', - SO2NR'R", NR'R" or SR' where R' and R'' are independently H, C1-C6alkyl or C3-C8cycloalkyl; R1selected from the group consisting of phenyl, naphthyl, 5- or 6-membered heteroaryl or heterocyclic containing one, two, three or four heteroatoms selected from the group consisting of N, S and O atoms; and, a 9- or 10-membered bicyclic aryl, heteroaryl or heterocyclic containing one, two or three heteroatoms selected from the group consisting of N, S and O atoms; wherein each of said phenyl, naphthyl, aryl, heterocyclic, or heteroaryl may be unsubstituted or substituted by halo, cyano, deuterium, hydroxy, C1-C6alkyl, C1-C6alkoxy, phenyl, -SO2-R', -CONR'R", NR'COR", -NR'CONR'R", -NR'CO2R", -(CH2)n-SO2-R', -NHSO2-R', -NR"SO2-R, -SO2NR'R", P(O)R'R", Formula (Ic), or NR'R"' or SR' where R' and R'' are independently H, C1-C6alkyl or C3-C8cycloalkyl; and,mandnare independently 0, 1, 2 or 3. The invention also relates to pharmaceutically acceptable salts of these compounds and to pharmaceutically acceptable solvates thereof; to compositions containing such compounds; and to the uses of such compounds in the treatment of various diseases, particularly acne.
• CN115417804
  申请人：——

  公开号：——

  公开（公告）日：——